The statutory purposes are clearly laid out in the Bill, building on the provisions in the 1990 Act. I do not remember whether the hon. Gentleman was in the House in 1990. I was, and I remember that the matter was fully debated at that time, and that many of these purposes were considered.
No human admixed embryo that has been created may be implanted into a woman or an animal, or be cultured for more than 14 days or after the appearance of the primitive streak. Equally, any research done using human embryos must satisfy the HFEA that it is necessary or desirable for one of the statutory purposes. This research is about giving scientists the ability, within clear boundaries—which have been discussed in the House before, particularly in 1990—within which to advance technologies that could help in the development of treatments for devastating degenerative conditions, in continuing research into male infertility and in learning more about what makes embryonic stem cells so different from any other cell.
The use of animal eggs will provide a valuable resource to embryo research scientists, giving them the ability to perfect the techniques that could one day help to develop our understanding of diseases and to speed up the development of their cures. My right hon. Friend the Member for Manchester, Gorton (Sir Gerald Kaufman) made a very eloquent speech earlier. I make no apology to the House for saying that we cannot promise that this research will definitely lead to those treatments; it is an aspiration that it could do so, if it is permitted, along with the rest of the research that is being carried out.
Amendments Nos. 1, 2, 41 and 42 would prohibit the creation of all forms of human admixed embryos for any purpose, including cytoplasmic hybrid embryos. A major barrier to continuing embryonic stem-cell research is the lack of human eggs for use in research, as they can be obtained only through the stimulation of a woman's ovaries. That procedure is not without risk, and the best eggs are quite rightly used in treatment. Researchers have been looking for a solution to the shortage, and they believe that they have found one in the form of animal eggs, which are widely available and believed to be as useful in the creation of embryos as human eggs. If successful, they could advance embryonic stem-cell research by many years.
The hon. Member for Boston and Skegness (Mark Simmonds), in speaking to amendments Nos. 10 and 11, sought to prohibit embryos created from the mixing of human and animal gametes—the so-called true hybrids. I must admit that I was not clear about the ethical principle that the hon. Gentleman was drawing on. In fairness to him, however, let me say that that was also reflected in the way in which the Government proceeded in their consideration of the matter. The hon. Gentleman asked for an explanation.
The Government took into account the arguments of the joint pre-legislative scrutiny Committee—a Committee of this House and the other place—which saw no clear reason to preclude such activity within the regulatory controls of the Human Fertility and Embryology Authority. Any project to create true hybrids would need to satisfy the research licensing criteria that the work is necessary or desirable for a statutory research purpose and that the use of the embryos is necessary. The hon. Member for Harrogate and Knaresborough (Mr. Willis), who chaired the Joint Committee, said on Second Reading that"““once we mix in any elements of animal, the principle of using hybrids for research purposes is established…That is the point that the Committee was trying to make; once we go down that road””—"
which we already have—"““it seems illogical to rule something out because of a particular mix.””—[Official Report, 12 May 2008; Vol. 475, c. 1068.]"
The Government agreed with that conclusion.
The Academy of Medical Sciences, the Royal Society, the Wellcome Trust and the Medical Research Council have written to say that true hybrids offer significant potential for research to improve our understanding of infertility, sperm function and stem-cell development—and must not be prohibited. Given that the hon. Member for Boston and Skegness could not set out a clear reason for this particular deletion, I urge the House to resist his amendment.
Human Fertilisation and Embryology Bill [Lords]
Proceeding contribution from
Baroness Primarolo
(Labour)
in the House of Commons on Monday, 19 May 2008.
It occurred during Debate on bills
and
Committee of the Whole House (HC) on Human Fertilisation and Embryology Bill [Lords].
Type
Proceeding contribution
Reference
476 c56-8 
Session
2007-08
Chamber / Committee
House of Commons chamber
Subjects
Librarians' tools
Timestamp
2023-12-16 01:40:57 +0000
URI
http://data.parliament.uk/pimsdata/hansard/CONTRIBUTION_474153
In Indexing
http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/pimsdata/hansard/CONTRIBUTION_474153
In Solr
https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/pimsdata/hansard/CONTRIBUTION_474153